With millions of people using injectable GLP-1 medications like Ozempic, Wegovy or Zepbound, many may wonder what happens if they stop. Previous clinical trials suggested a discouraging “rebound” effect, where patients regained a significant portion of their lost weight almost immediately after ending treatment. However, a new study from Cleveland Clinic, published in the journal … Read more
Newswise — MIAMI (March 16, 2026) – Cancer treatment is often described as a race against time. But for many patients, chemotherapy-induced thrombocytopenia (CIT) creates a roadblock—forcing clinicians to delay or reduce treatment. A new phase 3 clinical trial published in The New England Journal of Medicine suggests there may now be a way to … Read more
Pregnant and breastfeeding women have historically been excluded from medical research, resulting in substantial gaps in evidence on the safety and efficacy of medicines and vaccines. Analysis led by the Global Observatory on Health Research and Development of all clinical trials in the International Clinical Trials Registry Platform (ICTRP) reveals that just 4% of clinical trials … Read more
Newswise — Researchers at the University of California San Diego and collaborators have discovered a new way to help the immune system fight ovarian cancer by changing how tumors communicate with nearby immune cells. The study found that blocking a protein called FAK (focal adhesion kinase), which is highly active in many ovarian cancers, can … Read more
A new experimental cholesterol-lowering pill and recent advances in oral diabetes treatments are reinforcing a broader shift toward earlier, less invasive management of cardiometabolic disease, as drugmakers and clinicians focus on prevention, adherence, and risk reduction in high-risk populations. “There are other pills that patients can add to their statins, but none come close to … Read more
UK Markey Cancer Center is the first site in the country to open a clinical trial for ZG006 (Alveltamig), an experimental drug that works by connecting disease-fighting T cells to cancer cells, allowing the body’s immune system to attack the cancer. RT’s Three Key Takeaways: First-in-U.S. immunotherapy trial: The University of Kentucky Markey Cancer Center … Read more
TOPLINE: Four clinical organizations jointly released a clinical advisory with evidence-based nutrition and lifestyle interventions to enhance glucagon-like peptide 1 (GLP-1) treatment outcomes for obesity. METHODOLOGY: An expert group comprised of multiple clinical and research disciplines assessed the literature to identify pragmatic priorities for nutrition and other lifestyle interventions relevant to GLP-1 treatment for obesity. … Read more
Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates Should Ozempic be added to the water supply? That is the kind of half-joking question that doctors kick around when a new class of drugs begins to help a big… You can read the full story here: Ozempic: Should You Be Taking It?. Source … Read more
TOPLINE: In a study, patients who received a team-based intervention involving education and mobile health support in the emergency department (ED) had greater reduction in systolic blood pressure (SBP) at 6 months than those who received standard discharge care. METHODOLOGY: A randomized clinical trial enrolled 574 adult patients (mean age, 51.1 years) with elevated BP … Read more
Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates Revolutionary Immunotherapy: Dostarlimab Poised to Transform Solid Tumor Treatment A groundbreaking phase 2 trial indicates that dostarlimab, an innovative immunotherapy drug, is showing remarkable promise in treating early-stage solid tumors. the study reveals that complete responses to dostarlimab in neoadjuvant settings are enabling many … Read more